Overview
IGC market data
Price History
IGC price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for IGC. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
'THC And CBD From Marijuana Reduces Agitation In 9 Out Of 10 People With Alzheimer’s Or Other Dementia, Study Shows' - Marijuana MomentBenzinga · Jul 20, 2026, 3:12 PM
8-K filing — IGC Pharma, Inc. (IGC)SEC EDGAR · Jul 13, 2026, 10:11 PM
IGC Pharma Says CEO Ram Mukunda And Principal Financial Officer Claudia Grimaldi Purchase Aggregate Of 4,274,853 Shares Directly From Company At $0.27/ShrBenzinga · Jul 7, 2026, 1:10 PM
IGC Pharma Launches AI-Powered Data Harmonization Platform To Accelerate Alzheimer’s Research And Drug DiscoveryBenzinga · Jun 23, 2026, 12:40 PM
'White House Pushes Congress To Keep Hemp CBD Products Legal By Amending Broad Ban That's Set To Take Effect Later This Year' - Marijuana MomentBenzinga · Jun 5, 2026, 12:00 PM
IGC Pharma Announces Addition Of Icahn School Of Medicine At Mount Sinai In New York As Clinical Site In Phase 2 CALMA Trial Evaluating IGC-AD1 For Agitation Associated With Alzheimer's DiseaseBenzinga · Jun 2, 2026, 12:41 PM
"Marijuana Components Have 'Consistent' Anti-Tumor Effects In Glioblastoma And Other Cancers, Scientific Review Shows" - Marijuana MomentBenzinga · May 29, 2026, 3:15 PM